erlotinib hydrochloride has been researched along with Experimental Radiation Injuries in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, NJ; Chute, JP; Deoliviera, D; Doan, PL; Fixsen, E; Harris, JR; Helms, K; Himburg, HA; Kirsch, DG; Quarmyne, M; Russell, JL; Sullivan, JM | 1 |
1 other study(ies) available for erlotinib hydrochloride and Experimental Radiation Injuries
| Article | Year |
|---|---|
Epidermal growth factor regulates hematopoietic regeneration after radiation injury.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Epidermal Growth Factor; ErbB Receptors; Erlotinib Hydrochloride; Female; Hematopoiesis; Hematopoietic Stem Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Protein Kinase Inhibitors; Quinazolines; Radiation Injuries, Experimental; Regeneration; Signal Transduction; Tumor Suppressor Proteins; Whole-Body Irradiation | 2013 |